Preliminary Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth ...
A research team presents an overview of recent advances in the microbial biosynthesis of L-tryptophan (L-Trp) and its ...
AZoLifeSciences on MSN
Synthetic biology and metabolic engineering drive microbial L-tryptophan biomanufacturing
This review synthesizes progress in pathway optimization, regulatory rewiring, and microbial cell factory design that has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback